Abstract
This study describes the results of scintigraphy with99mTc-labeled methylene-diphosphonate (99mTc-MDP) and pyrophosphate (99mTc-PYP) as a noninvasive test for the distribution of organ involvement in five different types of amyloidosis. Scintigraphy with99mTc-labeled phosphates appeared to be a sensitive noninvasive screening test for the extent and the distribution of organ involvement in systemic AA and systemic AL amyloidosis as well as in local bronchial amyloid, local dermal amyloid, and familial amyloidotic polyneuropathy. Echocardiography, however, was more sensitive for demonstrating cardiac involvement in systemic amyloidosis than99mTc-MDP or99mTc-PYP scintigraphy.99mTc-MDP images showed a better contrast than99mTc-PYP images, although there was no difference in. the extent or the intensity of soft-tissue uptake.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amir J, Kessler E, de Vries A (1971) Skin and mucosal hemorrhage of prolonged duration in systemic amyloidosis. Blood 37:530–533
Bada JL, Padro L, Cervera C (1977) Scanning for soft-tissue amyloid. Lancet i:1012
Braun SD, Lisbona R, Novalez-Diaz JA, Sniderman A (1979) Myocardial uptake of 99m-Tc-phosphate tracer in amyloidosis. Clin Nucl Med 4:244–245
Brill DR (1981) Radionuclide imaging of nonneoplastic soft tissue disorders. Semin Nucl Med 11:277–288
Carroll J, Gaasch WH, McAdam KPWJ (1982) Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol 49:9–14
Cohen AS (1967) Amyloidosis. N Engl J Med 277:628–638
Cohen AS (1976) Approaches to the study of amyloid and the diagnosis of amyloidosis. In: Wegelius O, Pasternack A (eds) Amyloidosis. Academic Press, London
Cohen AS, Shirahama T (1973) Electron microscopic analysis of isolated fibrils from patients with primary, secondary and myeloma-associated disease: a study utilizing shadowing and negative staining techniques. Isr J Med Sci 9:849–856
Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS (1983) Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol 51:826–830
Furie B, Green E, Furie BC (1977) Syndrome of acquired factor X deficiency and systemic amyloidosis. In vivo studies of the metabolic fate of factor X. N Engl J Med 297:81–85
Furie B, Li Ann Voo BS, McAdam KPWJ, Furie BC (1981) Mechanism of factor X deficiency in systemic amyloidosis. N Engl J Med 304:827–830
Gertz MA, Brown ML, Hauser MF, Kyle RA (1987) Utility of technetium99mTc pyrophosphate bone scanning in cardiac am yloidosis. Arch Intern Med 147:1039–1044
Glenner GG (1980) Amyloid deposits and amyloidosis. Theβ-fibrilloses. N Engl J Med 302:1283–1292, 1333–1343
Glenner GG, Costa PP, Freitas AF (1980) Amyloid and amyloidiosis. Excerpta Medica, Amsterdam
Hawkins PN, Myers MJ, Lavender JP, Pepys MB (1988) Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P-component. Lancet 1:1413–1418
Janssen S, van Rijswijk MH, Piers DA, de Jong GMT (1984) Softtissue uptake of 99m-Tc-diphosphonate in systemic AL amyloidosis. Eur J Nucl Med 9:538–541
Janssen S, Elema JD, van Rijswijk MH, Limburg PC, Meijer S, Mandema E (1985) Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis. Appl Pathol 3:29–38
Johnston JB, Rayner HL, Trevenen C, Greenberg D (1982) Skeletal muscle uptake of Tc-99m-pyrophosphate in amyloidosis. Am J Hematol 13:247–251
Kula RW, Engel WK, Line BR (1977) Scanning for soft-tissue amyloid. Lancet 1:92–93
Kyle RA, Bayrd ED (1975) Amyloidosis: review of 236 cases. Medicine 54:271–299
Kyle RA, Greip PR (1983) Amyloidosis (AL). Clinical and laboratory features of 229 cases. Mayo Clin Proc 58:665–683
Lee VW, Caldarone AG, Falk RH, Rubinow A, Cohen AS (1983) Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Radiology 148:239–242
Lee VW, Rubinow A, Pehrson J, Skinner M, Cohen AS (1984) Amyloid goiter: preoperative scintigraphic diagnosis using Tc99m pyrophosphate. J Nucl Med 25:468–471
Moreno AJ, Brown JM, Brown TJ, Graham GD, Yedinak MA (1983) Scintigraphic findings in primary cerebral amyloidoma. Clin Nucl Med 8:528–530
Moyle JW, Spies SM (1980) Bone scan in a case of amyloidosis. Clin Nucl Med 5:51–52
Pepys MB (1981) Serum C-reactive protein, serum amyloid P-component and serum amyloid A protein in autoimmune disease. Clinics Immunol Allergy 1:77–101
Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS (1979) Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol 38:284–293
Rao BK, Padmalatha C, Au Buchon J, Lieberman LM (1981) Hepatic and splenic scintigraphy in idiopathic systemic amyloidosis. Eur J Nucl Med 6:143–146
Reuter E, Bethge N, Matthes M, Koppenhagen K (1983) 99m-Tc pyrophosphates for imaging of amyloid in C-cell carcinoma. Eur J Nucl Med 8:398–400
Rosenthall L, Kaye M (1975) Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease. J Nucl Med 16:33–39
Rudd TG, Allen DR, Hartnett DE (1977) Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison. J Nucl Med 18:872–877
Schiff S, Bateman T, Moffatt R, Davidson R, Berman D (1982) Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyro- phosphate uptake in amyloid heart disease. Am Heart J 103:562–563
Shirahama T, Skinner M, Cohen AS, Benson MD (1977) Uncertain value of urinary sediments in the diagnosis of amyloidosis. N Engl J Med 297:821–823
Sobol SM, Brown JM, Bunker SR, Patel J, Lull RJ (1982) Noninvasive diagnosis of cardiac amyloidosis by technetium-99mpyrophosphate myocardial scintigraphy. Am Heart J 103:563–566
Van Antwerp JD, O'Mara RE, Pitt MJ, Walsh S (1975) Technetium-99m diphosphonate accumulation in amyloid. J Nucl Med 16:238–240
Vanek JA, Cook SA, Bukowski RM (1977) Hepatic uptake of Tc-99m-labeled diphosphonate in amyloidosis: case report. J Nucl Med 18:1086–1088
van Rijswijk MH, van Heusden CWGJ (1979) The potassium permanganate method: a reliable method for differentiating amyloid AA from other forms in routine laboratory practice. Am J Pathol 97:43–58
Wizenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM (1982) Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the non-invasive diagnosis of amyloidosis. Am Heart J 103:468–473
Yood RA, Skinner M, Cohen AS, Lee VW (1981) Soft tissue uptake of bone-seeking radionuclide in amyloidosis. J Rheumatol 8:760–766
Yood RA, Skinner M, Rubinow A, Talarico L, Cohen AS (1983) Bleeding manifestations in 100 patients with amyloidosis. J Am Med Assoc 249:1322–1324
Author information
Authors and Affiliations
Additional information
This study was supported by a grant from the Dutch Kidney Foundation
Present address: St Jozef Hospital, Graaf Florisweg 77-79, 2805 AH Gouda, The Netherlands
Rights and permissions
About this article
Cite this article
Janssen, S., Piers, D.A., van Rijswijk, M.H. et al. Soft-tissue uptake of99m-Tc-diphosphonate and99mTc-pyrophosphate in amyloidosis. Eur J Nucl Med 16, 663–670 (1990). https://doi.org/10.1007/BF00998166
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00998166